# A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Bioavailability, and Food-effects of EA1080 in Healthy Caucasian and Japanese Male Participants

> **NCT04223960** · PHASE1 · COMPLETED · sponsor: **EA Pharma Co., Ltd.** · enrollment: 184 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** EA1080
- **DRUG:** EA1080
- **DRUG:** EA1080
- **DRUG:** EA1080
- **DRUG:** EA1080-matching placebo
- **DRUG:** EA1080
- **DRUG:** EA1080

## Key facts

- **NCT ID:** NCT04223960
- **Lead sponsor:** EA Pharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-09
- **Primary completion:** 2023-08-06
- **Final completion:** 2023-08-06
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2023-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04223960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04223960, "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Bioavailability, and Food-effects of EA1080 in Healthy Caucasian and Japanese Male Participants". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04223960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*